Metastasis represents the leading cause of death in
lung cancer patients. C-X-C Motif
Chemokine Ligand 8 (CXCL-8),
Chemokine (C-C motif)
ligand 20 (CCL-20) and
heme oxygenase -1 (HO-1) play an important role in
cancer cell proliferation and migration.
Berberine is an
isoquinoline alkaloid isolated from several herbs in the Papaveraceae family that exhibits anti-inflammatory, anticancer and
antidiabetic properties. Therefore, the aim of present study is to investigate the inhibitory potential of
berberine monoolein loaded liquid crystalline nanoparticles (
berberine-LCNs) against
cancer progression.
Berberine-LCNs were prepared by mixing
berberine,
monoolein and
poloxamer 407 (P407) using ultrasonication method. A549 cells were treated with or without 5 µM dose of
berberine LCNs for 24 hr and total cellular
protein was extracted and further analyzed for the
protein expression of CCl-20, CXCL-8 and HO-1 using human oncology array kit. Our results showed that
berberine-LCNs significantly reduced the expression of CCl-20, CXCL-8 and HO-1 at dose of 5µM. Collectively, our findings suggest that
berberine-LCNs have inhibitory effect on
inflammation/oxidative stress related
cytokines i.e. CCL20, CXCL-8, and HO-1 which could be a novel therapeutic target for the management of
lung cancer. PRACTICAL APPLICATIONS:
Berberine is an
isoquinoline alkaloid extracted from various plants of Papaveraceae family. CXCL-8, CCL-20 and HO-1 play an important role in
cancer progression. Our study showed that
Berberine LCNs significantly downregulate the expression of CXCL-8, CCL-20 and HO-1 which suggests that
Berberine loaded nanoparticles could be a promising therapeutic alternative for the management of
lung cancer.